South Africa's ''Rollout'' of Highly Active Antiretroviral Therapy: A Critical Assessment

Simple item page
dc.contributor.authorNattrass, Nicoli
dc.date.accessioned2016-05-25T12:35:28Z
dc.date.available2016-05-25T12:35:28Z
dc.date.issued2006
dc.date.updated2016-05-25T12:33:21Z
dc.description.abstractThe number of people on highly active antiretroviral therapy (HAART) in South Africa has risen from ,2000 in October 2003, to almost 200,000 by the end of 2005. Yet South Africa’s performance in terms of HAART coverage is poor both in comparison with other countries and the targets set by the government’s own Operational Plan. The public-sector HAART ‘‘rollout’’ has been uneven across South Africa’s nine provinces and the role of external assistance from NGOs and funding agencies such as the Global Fund and PEPFAR has been substantial. The National Treasury seems to have allocated sufficient funding to the Department of Health for a larger HAART rollout, but the Health Minister has not mobilized it accordingly. Failure to invest sufficiently in human resources— especially nurses—is likely to constrain the growth of HAART coverage.en_ZA
dc.identifierhttp://dx.doi.org/10.1097/01.qai.0000242456.05274.fb
dc.identifier.apacitationNattrass, N. (2006). South Africa's ''Rollout'' of Highly Active Antiretroviral Therapy: A Critical Assessment. <i>Journal of Acquired Immune Deficiency Syndrome</i>, http://hdl.handle.net/11427/19851en_ZA
dc.identifier.chicagocitationNattrass, Nicoli "South Africa's ''Rollout'' of Highly Active Antiretroviral Therapy: A Critical Assessment." <i>Journal of Acquired Immune Deficiency Syndrome</i> (2006) http://hdl.handle.net/11427/19851en_ZA
dc.identifier.citationNattrass, N. (2006). South Africa's “rollout” of highly active antiretroviral therapy: a critical assessment. JAIDS Journal of Acquired Immune Deficiency Syndromes, 43(5), 618-623.en_ZA
dc.identifier.ris TY - Journal Article AU - Nattrass, Nicoli AB - The number of people on highly active antiretroviral therapy (HAART) in South Africa has risen from ,2000 in October 2003, to almost 200,000 by the end of 2005. Yet South Africa’s performance in terms of HAART coverage is poor both in comparison with other countries and the targets set by the government’s own Operational Plan. The public-sector HAART ‘‘rollout’’ has been uneven across South Africa’s nine provinces and the role of external assistance from NGOs and funding agencies such as the Global Fund and PEPFAR has been substantial. The National Treasury seems to have allocated sufficient funding to the Department of Health for a larger HAART rollout, but the Health Minister has not mobilized it accordingly. Failure to invest sufficiently in human resources— especially nurses—is likely to constrain the growth of HAART coverage. DA - 2006 DB - OpenUCT DP - University of Cape Town J1 - Journal of Acquired Immune Deficiency Syndrome LK - https://open.uct.ac.za PB - University of Cape Town PY - 2006 T1 - South Africa's ''Rollout'' of Highly Active Antiretroviral Therapy: A Critical Assessment TI - South Africa's ''Rollout'' of Highly Active Antiretroviral Therapy: A Critical Assessment UR - http://hdl.handle.net/11427/19851 ER - en_ZA
dc.identifier.urihttp://hdl.handle.net/11427/19851
dc.identifier.urihttp://journals.lww.com/jaids/Abstract/2006/12150/South_Africa_s__Rollout__of_Highly_Active.19.aspx
dc.identifier.vancouvercitationNattrass N. South Africa's ''Rollout'' of Highly Active Antiretroviral Therapy: A Critical Assessment. Journal of Acquired Immune Deficiency Syndrome. 2006; http://hdl.handle.net/11427/19851.en_ZA
dc.languageengen_ZA
dc.publisherCelia Braithwaiten_ZA
dc.publisher.departmentCentre for Social Science Research(CSSR)en_ZA
dc.publisher.facultyFaculty of Humanitiesen_ZA
dc.publisher.institutionUniversity of Cape Town
dc.sourceJournal of Acquired Immune Deficiency Syndromeen_ZA
dc.source.urihttp://journals.lww.com/jaids/pages/default.aspx
dc.subject.otherAIDS
dc.subject.otherSouth Africa
dc.subject.otherantiretrovirals
dc.subject.otherHAART
dc.titleSouth Africa's ''Rollout'' of Highly Active Antiretroviral Therapy: A Critical Assessmenten_ZA
dc.typeJournal Articleen_ZA
uct.type.filetypeText
uct.type.filetypeImage
uct.type.publicationResearchen_ZA
uct.type.resourceArticleen_ZA
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Nattrass_South_Africa_039_s_039_039_Rollout_039_039_2006.pdf
Size:
442.08 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.72 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Journal Articles